Literature DB >> 27585665

Recent progress toward the use of circulating microRNAs as clinical biomarkers.

Vikas Ghai1, Kai Wang2.   

Abstract

MicroRNAs (miRNAs) have been shown to be critical mediators of many cellular and developmental processes and have been implicated in different human diseases. Since the observation of extracellular miRNAs present in various biofluids, much attention and excitement have been garnered toward understanding the functional roles of these circulating extracellular miRNAs and establishing their potential use as noninvasive diagnostic biomarkers. Here, we will review the current state of miRNA biomarkers for many human diseases, including their emerging use in toxicological applications, and discuss the current challenges in the field, with an emphasis on technical issues that often hinder discovery-based miRNA biomarker studies.

Entities:  

Keywords:  Biomarkers; Cancer; Cardiovascular disease; Diabetes; MiRNAs; Toxicology

Mesh:

Substances:

Year:  2016        PMID: 27585665     DOI: 10.1007/s00204-016-1828-2

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  37 in total

Review 1.  Circulating miRNAs and miRNA shuttles as biomarkers: Perspective trajectories of healthy and unhealthy aging.

Authors:  Fabiola Olivieri; Miriam Capri; Massimiliano Bonafè; Cristina Morsiani; Hwa Jin Jung; Liana Spazzafumo; Jose Viña; Yousin Suh
Journal:  Mech Ageing Dev       Date:  2016-12-13       Impact factor: 5.432

2.  Decreased miR-17-92 cluster expression level in serum and granulocytes preceding onset of antithyroid drug-induced agranulocytosis.

Authors:  Jing Yang; Yuncheng Lv; Yi Zhang; Jiaoyang Li; Yajun Chen; Chang Liu; Jing Zhong; Xinhua Xiao; Jianghua Liu; Gebo Wen
Journal:  Endocrine       Date:  2017-12-18       Impact factor: 3.633

Review 3.  Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy.

Authors:  Yu Zhang; Xinghui Sun; Basak Icli; Mark W Feinberg
Journal:  Endocr Rev       Date:  2017-04-01       Impact factor: 19.871

4.  Alterations in Plasma microRNA and Protein Levels in War Veterans with Chronic Mild Traumatic Brain Injury.

Authors:  Vikas Ghai; Shannon Fallen; David Baxter; Kelsey Scherler; Taek-Kyun Kim; Yong Zhou; James S Meabon; Aric F Logsdon; William A Banks; Abigail G Schindler; David G Cook; Elaine R Peskind; Inyoul Lee; Kai Wang
Journal:  J Neurotrauma       Date:  2020-03-11       Impact factor: 5.269

5.  Helix-7 in Argonaute2 shapes the microRNA seed region for rapid target recognition.

Authors:  Shannon M Klum; Stanley D Chandradoss; Nicole T Schirle; Chirlmin Joo; Ian J MacRae
Journal:  EMBO J       Date:  2017-09-22       Impact factor: 11.598

6.  MicroRNA 21 Elicits a Pro-inflammatory Response in Macrophages, with Exosomes Functioning as Delivery Vehicles.

Authors:  Radha Madhyastha; Harishkumar Madhyastha; Queen Intan Nurrahmah; Bethasiwi Purbasari; Masugi Maruyama; Yuichi Nakajima
Journal:  Inflammation       Date:  2021-01-26       Impact factor: 4.092

7.  Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1.

Authors:  A Perfetti; S Greco; R Cardani; B Fossati; G Cuomo; R Valaperta; F Ambrogi; A Cortese; A Botta; A Mignarri; M Santoro; C Gaetano; E Costa; M T Dotti; G Silvestri; R Massa; G Meola; F Martelli
Journal:  Sci Rep       Date:  2016-12-01       Impact factor: 4.379

Review 8.  Targeting MicroRNAs in Cancer Gene Therapy.

Authors:  Weidan Ji; Bin Sun; Changqing Su
Journal:  Genes (Basel)       Date:  2017-01-09       Impact factor: 4.096

9.  Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells.

Authors:  Gaofeng Liang; Shu Kan; Yanliang Zhu; Shuying Feng; Wenpo Feng; Shegan Gao
Journal:  Int J Nanomedicine       Date:  2018-01-30

Review 10.  MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions.

Authors:  Caterina Catalanotto; Carlo Cogoni; Giuseppe Zardo
Journal:  Int J Mol Sci       Date:  2016-10-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.